Abstract
We analyzed the effects of PUVA-bath therapy in fifty-one inpatients with psoriasis. Of these, thirty patients were followed twelve month after discharge. All patients had steroid and / or topical vitamin D ointment. The mean number of exposure was 13.4 times and the mean dose of UVA was 11.1J/cm2. Twenty-one patients had etretinate. PUVA-bath with etretinate was effective therapy to forty-seven patients(92%) as inpatients. Seven patients out of thirty outpatients(23%) had recurrence of psoriasis after discharge. The number of PUVA-bath therapy at 12 month after discharge is less than that at 6 month after discharge. Although some patients were resistant to the effects of cyclosporine or had side effects of cyclosporine, PUVA-bath therapy had effective on these patients. There were no side effects of PUVA-bath therapy. Taken together, PUVA-bath therapy with or without etretinate was useful to moderate to severe psoriasis patients.
